Semaglutide for $174/mo
Applicable Procedure Codes: E0193, E0194, E0250, E0251, E0255, E0256, E0260, E0261, E0265, E0266, E0277, E0280, E0290, E0291, E0292, E0293, E0294, E0295, E0296, E0297, E0300, E0301, E0302, E0303, E0304, E0305, E0310, E0316, E0328, E0329, E0910, E0911, E1399
At 68 weeks, CagriSema produced a mean body weight reduction of 22.7% from baseline
Real-world tracking of dozens of GLP-1 users over six months showed that inconsistent notes and anxiety magnified symptoms, while centralized, timestamped data clarified patterns and reduced unnecessary testing
GLP-1 agonists like semaglutide lower blood sugar through multiple mechanisms, creating significant hypoglycemia risk when combined with insulin